Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies

Journal of Clinical Microbiology

Volumn 37, Issue 4, 1999, Pages 1013-1017

  Tiran, Andreas ^a   Tio, Rene A ^b   Ossewaarde, Jacobus M ^c   Tiran, Beate ^a   Den Heijer, Peter ^b   The, T Hauw ^d   Wilders Truschnig, Martie M ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; RICKETTSIALES;

EID: 0033065968     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.4.1013-1017.1999     Document Type: Article

References (30)

1. Brade, L., H. Brunnemann, M. Ernst, V. Fu, O. Holst, P. Kosma, H. Naher, K. Persson, and H. Brade. 1994. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol. Med. Microbiol. 8:27-41.
2. Califf, R. M., E. M. Ohman, D. J. Frid, D. F. Fortin, D. B. Mark, M. A. Hlatky, J. E. Herndon, and J. R. Bengtson. 1990. Restenosis: the clinical issues, p. 363-394. In E. J. Topol (ed.), Textbook of interventional cardiology. W. B. Saunders Co., Philadelphia, Pa.
3. Campbell, L. A., E. R. O'Brien, A. L. Cappuccio, C. C. Kuo, S. P. Wang, D. Stewart, D. L. Patton, P. K. Cummings, and J. T. Grayston. 1995. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172:585-588.
4. Carlsson, J., S. Miketic, K. H. Mueller, J. Brom, R. Ross, R. von Essen, and U. Tebbe. 1997. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Lancet 350:1225.
5. Danesh, J., R. Collins, and R. Peto. 1997. Chronic infections and coronary heart disease: is there a link. Lancet 350:430-436.
6. Gordon, P. C., S. P. Friedrich, R. N. Piana, A. D. Kugelmass, G. A. Leidig, C. M. Gibson, D. J. Cohen, J. P. Carrozza, R. E. Kuntz, and D. S. Baim. 1994. Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant? Am. J. Cardiol. 74: 26-32.
7. Grayston, J. T., L. A. Campbell, C. C. Kuo, C. H. Mordhorst, P. Saikku, D. H. Thom, and S. P. Wang. 1990. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 161:618-625.
8. Jackson, L. A., L. A. Campbell, C. C. Kuo, D. I. Rodriguez, A. Lee, and J. T. Grayston. 1997. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J. Infect. Dis. 176:292-295.
9. Jukema, J. W., A. V. Bruschke, A. J. van Boven, J. H. Reiber, E. T. Bal, A. H. Zwinderman, H. Jansen, G. J. Boerma, F. M. van Rappard, and K. I. Lie. 1995. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91:2528-2540.
10. Kuo, C. C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
11. Ladany, S., C. M. Black, C. E. Farshy, J. M. Ossewaarde, and R. C. Barnes. 1989. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR). J. Clin. Microbiol. 27:2778-2783.
12. Leinonen, M., E. Linnanmaki, K. Mattila, M. S. Nieminen, V. Valtonen, M. Leirisalo Repo, and P. Saikku. 1990. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb. Pathog. 9:67-73.
13. Maass, M., C. Bartels, P. M. Engel, U. Mamat, and H. H. Sievers. 1998. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J. Am. Coll. Cardiol. 31:827-832.
14. Maass, M., and J. Gieffers. 1996. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol. Infect. Dis. 6:65-70.
15. Marrie, T. J., J. T. Grayston, S. P. Wang, and C. C. Kuo. 1987. Pneumonia associated with the TWAR strain of Chlamydia. Ann. Intern. Med. 106:507-511.
16. Meijer, A., P. J. M. Roholl, J. A. van der Vliet, F. K. Gielis-Proper, A. de Vries, and J. M. Ossewaarde. 1998. Differences in detection of chlamydia pneumoniae protein, hsp60, lipopolysaccharide and DNA in abdominal aneurysms, p. 191-194. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection, International Chlamydia Symposium, San Francisco, Calif.
17. Meyer, A., C. E. Vallinga, and J. M. Ossewaarde. 1996. A microcarrier culture method for the production of large quantities of viable Chlamydia pneumoniae. Appl. Microbiol. Biotechnol. 46:132-137.
18. Nissen, S. E., and J. C. Gurley. 1992. Assessment of coronary angioplasty results by intravascular ultrasound, p. 73-96. In P. W. Serruys, B. H. Strauss, and S. B. King (ed.), Restenosis after intervention with new mechanical devices. Kluwer Academic Publishers, Dordrecht, The Netherlands.
19. Ong, G., B. J. Thomas, A. O. Mansfield, B. R. Davidson, and R. D. Taylor. 1996. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J. Clin. Pathol. 49:102-106.
20. Ossewaarde, J. M., E. J. Feskens, A. de Vries, C. E. Vallinga, and D. Kromhout. 1998. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol. Infect. 120:93-99.
21. Ossewaarde, J. M., J. W. Manten, H. J, Hooft, and A. C. Hekker. 1989. An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis. J. Immunol. Methods 123: 293-298.
22. Quyyumi, A. A., M. Raphael, E. J. Perrins, L. M. Shapiro, A. F. Rickards, and K. M. Fox. 1986. Incidence of spasm at the site of previous successful transluminal coronary angioplasty: effect of ergometrine maleate in consecutive patients. Br. Heart J. 56:27-32.
23. Ramirez, J. A. 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann. Intern. Med. 125:979-982.
24. Saikku, P. 1993. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur. Heart J. 14(Suppl. K):62-65.
25. Shor, A., C. C. Kuo, and D. L. Patton. 1992. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. 82:158-161.
26. Stanek, G., K. Huber, D. Glogar, M. Maurer, and M. Kundi. 1997. Chlamydia antibodies in patients with coronary artery disease. Hospitalis 67:18.
27. Van der Giessen, M., A. P. Van den Berg, W. van der Bij, S. Postma, W. J. Van Son, and T. H. The. 1990. Quantitative measurement of cytomegalovirus-specific 1gG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection. Clin. Exp. Immunol. 80:56-61.
28. Verkooyen, R. P. 1997. Chlamydia pneumoniae - studies on an emerging pathogen. Ph.D. thesis. University of Rotterdam, Rotterdam, The Netherlands.
29. Verkooyen, R. P., N. A. Van Lent, S. A. M. Joulandan, R. J. Snijder, J. M. Van den Bosch, H. P. Van Helden, and H. A. Verbrugh. 1997. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by microimmunofluorescence and ELISA. J. Med. Microbiol. 46:959-964.
30. von Essen, R., R. Ostermaier, E. Grube, W. Maurer, V. Tebbe, R. Erbel, M. Roth, W. Oel, J. Brom, and G. Weidinger. 1997. Effects of octreotide treatment on rcstenosis after coronary angioplasty: results of the VERAS study. Circulation 96:1482-1487.